Juan Maya

1.9k citations

38 papers · 1.4k indexed · h-index 18

Impact in

Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management
Cardiology and Cardiovascular Medicine top 2%
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Myocardial Infarction Research
- Heart Failure Treatment and Management
- Atrial Fibrillation Management and Outcomes

Papers in

Internal Medicine 5
- Venous Thromboembolism Diagnosis and Management 5
Cardiology and Cardiovascular Medicine 26
- Antiplatelet Therapy and Cardiovascular Diseases 14
- Heart Failure Treatment and Management 9
- Heart rate and cardiovascular health 9
- Acute Myocardial Infarction Research 4

Co-authors: Robert F. Storey Stefan James Steen Husted Lars Wallentin J. Christopher Gorski Jan H. Cornel Renli Teng Stephen D. Hall
Journals: Journal of the American College of Cardiology (5 papers)Circulation (3 papers)Journal of Cardiac Failure (2 papers)JACC: Cardiovascular Interventions (2 papers)Current Medical Research and Opinion (2 papers)
Partner nations: United States United Kingdom France

In The Last Decade

Juan Maya

36 papers receiving 1.3k citations

Peers

Countries citing papers authored by Juan Maya

Since Specialization

Citations

This map shows the geographic impact of Juan Maya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Maya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Maya more than expected).

Fields of papers citing papers by Juan Maya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan Maya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Maya. The network helps show where Juan Maya may publish in the future.

Co-authors

The 25 scholars most cited alongside Juan Maya, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Juan Maya Line = papers co-authored together Juan Maya links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Genetics of heart rate in heart failure patients (GenHRate) Human Genomics ·Kaleigh L. Evans, Heidi S. Wirtz, Jia Li, Ruicong She, Juan Maya, Hongsheng Gui, Andrew Hamer, Christophe Depré, David E. Lanfear	2019	9
2	Medication-Taking Behaviors and Perceptions Among Adults With Heart Failure (from the REasons for Geographic And Racial Differences in Stroke Study) The American Journal of Cardiology ·Matthew T. Mefford, L. K. Tempest, Melissa K. Van Dyke, Ligong Chen, Raegan W. Durant, Todd M. Brown, Matthew Fifolt, Juan Maya, Parag Goyal, Monika M. Safford, Emily B. Levitan	2019	2
3	CARDIOVASCULAR RISK IN PATIENTS DENIED ACCESS TO PCSK9I THERAPY Journal of the American College of Cardiology ·Seth J. Baum, Chi‐Chang Chen, Pallavi Rane, Jeetvan Patel, Juan Maya, David W. Harrison, Nicole Yurgin, Rolin L. Wade, Akin Mert	2018	6
4	Abstract 19090: Patient Characteristics and Lipid Lowering Treatment of Early Adopters of PCSK9i Therapies in the United States Circulation ·LK Carlisle, Sandra Dejardin, Heidi S. Wirtz, Juan Maya, Paul Muntner, Tracy Y Wang	2017	1
5	CHARACTERISTICS OF PATIENTS APPROVED AND DENIED ACCESS TO PCSK9I THERAPY BY PAYERS Journal of the American College of Cardiology ·Seth J. Baum, Chi‐Chang Chen, Pallavi Rane, Jeetvan Patel, Juan Maya, David J. Harrison, Nicole Yurgin, Rolin L. Wade	2017	4
6	CE-23 Epidemiological aspects and drugs used in a cohort of chilean systemic lupus erythematosus patients Óscar Neira, Luis E. Muñoz, Juan Maya, Kubodera Kuniharu	2016	0
7	Efficacy Profile of Ivabradine in Patients with Heart Failure plus Angina Pectoris Cardiology ·Jeffrey Borer, Karl Swedberg, Michel Komajda, Ian Ford, Luigi Tavazzi, Michael Böhm, Christophe Depré, Mia Zeric, Juan Maya, A Türeli	2016	15
8	BETA BLOCKER DOSAGE AND USE OVER TIME IN THE SYSTOLIC HEART FAILURE TREATMENT WITH THE IF INHIBITOR IVABRADINE TRIAL (SHIFT) STUDY Journal of the American College of Cardiology ·Jeffrey Borer, Karl Swedberg, Michel Komajda, Ian Ford, Luigi Tavazzi, Michael Böehm, A Türeli, Juan Maya, Mia Zeric	2015	3
9	Discharge heart rate and β-blocker dose in patients hospitalized with heart failure: Findings from the OPTIMIZE-HF registry American Heart Journal ·Adam D. DeVore, Xiaojuan Mi, Robert J. Mentz, Gregg C. Fonarow, Melissa K. Van Dyke, Juan Maya, N. Chantelle Hardy, Bradley G. Hammill, Adrian F. Hernandez	2015	26
10	TICAGRELOR VERSUS CLOPIDOGREL IN AFRICAN AMERICAN PATIENTS WITH CORONARY ARTERY DISEASE AND DIABETES MELLITUS Journal of the American College of Cardiology ·Ron Waksman, Juan Maya, Dominick J. Angiolillo, Glenn Carlson, Renli Teng, Richard Caplan, Keith C. Ferdinand	2014	2
11	Absolute bioavailability and regional absorption of ticagrelor in healthy volunteers PubMed ·Renli Teng, Juan Maya	2014	24
12	TICAGRELOR VERSUS CLOPIDOGREL IN PATIENTS WITH NON-ST-ELEVATION ACUTE CORONARY SYNDROME: RESULTS FROM THE PLATO TRIAL Journal of the American College of Cardiology ·Daniel Lindholm, Christoph Varenhorst, Christopher P. Cannon, Robert A. Harrington, Anders Himmelmänn, Juan Maya, Steen Husted, Hugo Katus, Philippe Gabríel Steg, Robert F. Storey, Lars Wallentin, Stefan James	2013	4
13	Angiographic Outcomes in the PLATO Trial (Platelet Inhibition and Patient Outcomes) JACC: Cardiovascular Interventions ·Vijay Kunadian, Stefan James, Daniel Wojdyla, Cafer Zorkun, Jinhui Wu, Robert F. Storey, Philippe Gabríel Steg, Hugo A. Katus, Håkan Emanuelsson, Jay Horrow, Juan Maya, Lars Wallentin, Robert A. Harrington, C. Michael Gibson	2013	30
14	Effect of ticagrelor on pulmonary function in healthy elderly volunteers and asthma or chronic obstructive pulmonary disease patients Current Medical Research and Opinion ·Kathleen Butler, Juan Maya, Renli Teng	2013	18
15	Is there an association between aspirin dosing and cardiac and bleeding events after treatment of acute coronary syndrome? A systematic review of the literature American Heart Journal ·Jeffrey S. Berger, Wilhelm Falke, Brian G. Katona, Juan Maya, Gayatri Ranganathan, Yingxin Xu, Mkaya Mwamburi	2012	22
16	Evaluation of the pharmacokinetics and pharmacodynamics of ticagrelor co-administered with aspirin in healthy volunteers Platelets ·Renli Teng, Juan Maya, Kathleen Butler	2012	35
17	Abstract 15029: Ticagrelor Versus Clopidogrel in Patients with Acute Coronary Syndromes and History of Stroke or Transient Ischemic Accident: Results from the Platelet Inhibition and Patient Outcomes Trial Circulation ·Stefan James, Robert F. Storey, Cheryl Bushnell, Jay Horrow, Steen Husted, Kenneth W. Mahaffey, Juan Maya, Richard C. Becker	2011	1
18	Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans British Journal of Clinical Pharmacology ·Zaiqi Wang, Stephen D. Hall, Juan Maya, Lang Li, Ali Asghar, J. Christopher Gorski	2003	172
19	The effects of an oral contraceptive containing ethinyloestradiol and norgestrel on CYP3A activity British Journal of Clinical Pharmacology ·P.A. Podyacheva, John T. Callaghan, J. Christopher Gorski, Juan Maya, Mariana Albuquerque Zan, Steven Wrighton, Stephen D. Hall	2002	54
20	Effects of Albumin/Furosemide Mixtures on Responses to Furosemide in Hypoalbuminemic Patients Journal of the American Society of Nephrology ·Naga Chalasani, Xueting Liu, John C. Horlander, D.M. Ward, Helena Hoen, Juan Maya, Brigida Ticiane Ferreira da Silva	2001	73

About Juan Maya

Juan Maya is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine, Family Practice, Surgery and Hepatology, having authored 38 papers that have together received 1.4k indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (14 papers), Lipoproteins and Cardiovascular Health (11 papers), Heart Failure Treatment and Management (9 papers), Heart rate and cardiovascular health (9 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers), Venous Thromboembolism Diagnosis and Management (5 papers), Pharmaceutical Economics and Policy (4 papers) and Acute Myocardial Infarction Research (4 papers). The work is most often cited by research in Internal Medicine (159 citations), Cardiology and Cardiovascular Medicine (907 citations), Family Practice (47 citations), Pharmacology (128 citations) and Endocrinology, Diabetes and Metabolism (181 citations). Juan Maya has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Robert F. Storey, Stefan James, Steen Husted, Lars Wallentin, J. Christopher Gorski, Jan H. Cornel, Renli Teng, Stephen D. Hall, Dominick J. Angiolillo and Susanna R. Stevens. Their work appears in journals such as Journal of the American College of Cardiology, Circulation, Journal of Cardiac Failure, JACC: Cardiovascular Interventions and Current Medical Research and Opinion.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact